ORGANIGRAM GLOBAL INC.
For the period ended Dec 31, 2025. Filed Dec 31, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Dec 31, 2025 · Filed Dec 31, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · About Phylos Bioscience Inc
About Phylos Bioscience Inc.
Phylos is a cannabis genetics company focused on producing scientifically bred genetics that enable the highest quality cannabis to be grown at scale in a cost-effective way. Phylos supports commercial-scale cultivation with the industry’s first Production-Ready Seed™: premium, phenotypically stable, fully feminized F1 hybrid seeds that deliver exceptional flower quality, potency, vigour, and yield.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.